Lightnews — Scholar-powered news

Dr Gabriela Khoury

@gabrielakhoury.bsky.social

820 followers 580 following 34 posts

Antiviral Immunity Theme Leader at Burnet Institute Melbourne. Exec CI PROPHECY COVID vaccine MRFF. LOC AVS2024. We study vaccine and viral immunity in vulnerable populations. Plus the impact of viruses on our health.

Posts Media Videos Starter Packs

Pinned

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Nov 19

A whole new world over here @bluesky! I am based at the Burnet Institute and my team study the impact of viral infections on health, immune responses to infections and vaccines in variety of vulnerable populations. #WomenInSTEM

The Antiviral Immunity team at Burnet consists of 5 female scientists who are in the photo.

3 40

Dr Gabriela Khoury @gabrielakhoury.bsky.social · 14d

In lab news this month! Congratulations to Maddison Cali, our honours student who was awarded the Best 10min talk at @burnetinstitute.bsky.social student symposium this month! 👏👏👏 Maddison studies post-acute infection syndromes including POTS and Long COVID. (📸Back row, on right end).

Eight research students who have won awards at the symposium are standing proudly holding their certificates.

1 1 4

Reposted by Dr Gabriela Khoury

Victorian Infection and Immunity Network @theviin.bsky.social · Aug 14

📝 Working on a manuscript? Not sure on how to navigate the submission process?

Join our next workshop “Manuscript Mastery” for all the tips and tricks on how to prepare your work for publication!

🕰️ Wed 10th Sept 10am - 12pm

Register by 5pm Friday 5th September
bit.ly/45gWCst

4 6

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Jun 25

Excited to share our 1st paper from our collaboration with @ianjohnwoolley.bsky.social & Spleen Australia is published! We describe predictors of VZV& shingles vaccine uptake in asplenia. Also a good reminder to all eligible adults to get their shingles vaccine! www.sciencedirect.com/science/arti...

Varicella zoster virus reactivation episodes and vaccination uptake in Spleen Australia registrants

The Australian National Immunisation Program recently made the recombinant zoster vaccine (RZV), Shingrix, available to First Nations people (Aborigin…

www.sciencedirect.com

2 3

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Jun 12

Proud supervisor moment this afternoon! Our honours student, Maddison, did a great job presenting their project on post-acute infection syndromes. There was heaps of interest and Maddison fielded many questions. 👏 Watch this space for updates on this exciting project! 🧪🥼🧫

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Jun 11

Ping @theviin.bsky.social

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Jun 11

Are you a spectral flow cytometry guru? Join my team @burnetinstitute.bsky.social in Melbourne, where you will contribute to vaccine immunological response studies in immunocompromised and vulnerable people.
www.seek.com.au/job/84837146...

Research Assistant - Flow Cytometry Job in Melbourne VIC - SEEK

Join a world-renowned research institute and work within our Antiviral Immunity Laboratory team!

www.seek.com.au

1 2 3

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Mar 14

I met Plum Stone @plumskyjam.bsky.social the founder of @saferairproject.bsky.social in Canberra last year. Plum is a passionate advocate for clean indoor air for all and lives with #LongCovid. Tune into @emergeaustralia.bsky.social podcast where she talks with CEO, Anne Wilson.

Emerge Australia @emergeaustralia.bsky.social · Mar 14

Specialist in cancer policy, Plum Stone, highlights health risks of poor indoor air quality through The Safer Air Project. she started following her long COVID battle. Check out her insights at vist.ly/3mxb88j.

1 1 6

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Mar 14

It is #LongCOVID Awareness Day. At least 10% of people will experience symptoms for many months, even years after COVID. These can be debilitating & impact everyday things we all take for granted. We hear you! Our lab is studying the causes behind LC. We hope to find better diagnostics & treatments.

A picture of a grey and teal ribbon with the word long COVID typed in white on the grey part. The title of the image says "Long COVID Awareness Day" and is dated 15 March 2025 which is today.

2 54 130

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Mar 3

Congratulations!

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Feb 19

Go team Burnet! 👏 It is amazing to think that a Hep C vaccine could be on the horizon. Great work by Dr Joey McGregor, Prof Heidi Drummer, Dr Andy Poumbourios the team. #lorneiandi @burnetinstitute.bsky.social

Victorian Infection and Immunity Network @theviin.bsky.social · Feb 19

Fantastic talk by Dr Joey McGregor from @burnetinstitute.bsky.social who presented exciting work on novel mRNA vaccine targets for Hepatitis C. #lorneiandi

2 6

Reposted by Dr Gabriela Khoury

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Nov 29

Check our piece on Long COVID in the @aunz.theconversation.com.
With @brendancrabb.bsky.social @mjlscoullar.bsky.social
#LongCOVID #SARSCoV2

The Conversation AUNZ @aunz.theconversation.com · Nov 28

Much, if not all, long COVID appears to be driven by the virus persisting in the body. Formal proof remains elusive but here’s what the science shows.

Long COVID appears to be driven by ‘long infection’. Here’s what the science says

Much, if not all, long COVID appears to be driven by the virus persisting in the body. Formal proof remains elusive but here’s what the science shows.

theconversation.com

6 13

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Feb 13

📚 For those of you out there interested in the role of SARS-COV-2 reservoirs and persistence in Long COVID. Check out our earlier perspective in @mja.com.au it came out late 2024 but certainly relevant today! #LongCOVID
onlinelibrary.wiley.com/doi/10.5694/...

Towards a cure for long COVID: the strengthening case for persistently replicating SARS‐CoV‐2 as a driver of post‐acute sequelae of COVID‐19

Click on the article title to read more.

onlinelibrary.wiley.com

2 10

Reposted by Dr Gabriela Khoury

PolyBio Research Foundation @polybiorf.bsky.social · Feb 11

1/ Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients

In a new report, global experts outline key considerations to address persistent SARS-CoV-2; provide a
roadmap to test critical new long COVID therapies

polybio.org/cutting-edge...

Cutting-edge Recommendations Provide Treatment Path for Millions of Long COVID Patients - PolyBio Research Foundation

In a new report, global experts outline key considerations to address persistent SARS-CoV-2; provide a roadmap to test critical new long...

polybio.org

11 55 110

Reposted by Dr Gabriela Khoury

Clinical Infectious Diseases @cidjournal.bsky.social · Feb 8

Long-COVID incidence proportion in adults and children between 2020 and 2024

✅ Just Accepted
#IDSky

Long-COVID incidence proportion in adults and children between 2020 and 2024

Incidence estimates of post-acute sequelae of SARS-CoV-2 infection, also known as long-COVID, have varied across studies and changed over time.

buff.ly

1 4 7

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Jan 29

🐳 Join us in sunny Lorne, Australia next month, 19-21 Feb, for the @theviin.bsky.social Infection and Immunity Conference. 🪼 Absolutely great line-up this year! In person (sea-side🐚) and virtual registration options available too. Don't miss out- www.lorneinfectionimmunity.org/registration

A photo of coastline called the great Ocean road in Victoria Australia. The water is blue and torquise. The waves crash on to rocky alcove and sandy beach. The conference is hosted at one of the local towns.

5 8

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 9

We found most KTx had impaired serological responses. Predictors of poor responses included higher mycophenolate dose and low B cell counts and in dialysis elevated monocyte counts. This work is a collaboration with Bill Mulley and colleagues at Monash Health. 2/2

1 1

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 9

Our other focus is studying vaccine responses in vulnerable people. In July we published our first study on serological responses & clinical outcomes of 3‐dose #COVID19 vaccine schedule in kidney #transplant recipients & people on #dialysis. doi.org/10.1002/cti2... More on these groups in 2025! 1/2

<em>Clinical & Translational Immunology</em> | ASI Journal | Wiley Online Library

In this study, we found that serological responses to COVID-19 vaccines in kidney transplant recipients lag behind people receiving dialysis by approximately one dose. Predictors of poor responses we...

doi.org

1 1 2

Reposted by Dr Gabriela Khoury

Jana Batovska @mozztacular.bsky.social · Dec 5

Very beneficial discussions during #AVS12 panel on Indigenous virology including how the Nagoya Protocol relates to our work - lots to learn but here is some basic information specific to Australia: www.dcceew.gov.au/science-rese...

www.dcceew.gov.au

1 3

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 5

What can researchers do right away? To start, non-indigenous people can up-skill with cultural sensitivity training to ensure we can create cultural safe workplaces for First Nations people. If your institution doesn't offer this campaign for access to this training #AVS12

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 5

Very interesting to understand the different perspectives on naming viruses isolated from country and also the data governance framework considerations when taking samples from the environment too. Looking forward to hearing more from a larger discussion from Alison Imrie. #AVS12

2 1

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 5

Both Natalie Netzlar and Trevor Lithgow emphasised that when working on country it is so important that community is involved from the start e.g. co-design and not just as 'sign off'. As Natalie nicely highlights it makes a huge difference to coming across as working 'on' vs 'with'.

1 1

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 4

Next up at #AVS12 is the Indigenous Virology session. Looking forward to hearing from the panel members - Natalie Netzlar, Allison Imrie, Trevor Lithgow &
Lloyd Dolan. To get insights on how AVS and research in general can improve representation of first nations people in the field of Virology.

1 1

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 4

Awesome thanks for creating such a valuable resource!

Dr Gabriela Khoury @gabrielakhoury.bsky.social · Dec 4

Such a great talk from Chantal Abergel @cnrs.bsky.social Viruses infecting other viruses! I wasn't expecting that. Wild! #AVS12